Virginia 2024 Regular Session

Virginia Senate Bill SB469

Introduced
1/9/24  
Refer
1/9/24  
Report Pass
1/17/24  
Report Pass
1/24/24  
Engrossed
1/26/24  
Refer
2/13/24  
Report Pass
2/23/24  
Refer
2/23/24  
Report Pass
2/28/24  
Enrolled
3/7/24  
Chaptered
4/4/24  

Caption

Controlled substances; manufacturing, selling, giving, distributing misbranded drugs, etc.

Impact

The bill will result in amending existing Virginia laws related to drug manufacturing and controlled substances. It introduces new provisions that specifically prohibit the presence of vulnerable groups during the manufacture of dangerous drugs, thereby enhancing legal protections for minors and incapacitated people. Moreover, it affects penalties associated with possession and distribution of manufacturing equipment used for drug production. As a consequence, local law enforcement agencies will have more authority and another legal tool at their disposal to combat illegal drug activities.

Summary

SB469 addresses the issues surrounding the manufacturing, selling, giving, and distributing of controlled substances, particularly targeting the illegal production of fentanyl and methamphetamine. The bill seeks to enact stringent penalties for individuals who allow minors or incapacitated persons to be present during the manufacturing process of these substances. Such actions would be classified as a felony offense, with punitive measures ranging between 10 to 40 years of imprisonment, depending on the severity of the violation. This bill is a significant step towards addressing the opioid crisis and substance abuse issues prevalent across the state.

Sentiment

The sentiment surrounding SB469 has been largely supportive among legislative members, as this bill is perceived as a necessary measure to tackle the serious issues of drug manufacturing and distribution. While proponents argue it will significantly deter illicit drug production practices, there are likely concerns about the implications of such severe penalties on families and the possible unintended consequences of criminalizing individuals who might not be the primary offenders. However, the overwhelming vote in favor of the bill indicates strong bipartisan support for its intent.

Contention

Despite general support, there are notable points of contention regarding the bill. Critics may argue about the harsh nature of the penalties, suggesting that the legislation could disproportionately impact individuals who may not fully comprehend their legal liabilities. Additionally, concerns could be raised about the potential for overreach in enforcement actions. There is also the challenge of effectively implementing these new laws and ensuring they do not inadvertently affect individuals who are not involved in serious offenses, thereby sparking a broader debate about the balance between public safety and individual rights.

Companion Bills

VA HB1042

Similar To Controlled substances; manufacturing, selling, giving, distributing misbranded drugs, etc.

Previously Filed As

VA SB1490

Fentanyl; selling, giving, or distributing a substance that contains 2 mgms. or more, etc.

VA HB1455

Fentanyl; selling, giving, or distributing a substance that contains 2 mgms. or more, penalties.

VA HB1973

Industrial hemp; selling or offering for sale a topical hemp product, etc.

VA SB888

Imprisonment; consecutive terms.

VA HB1922

Delta-8 tetrahydrocannabinol; distribution, penalty.

VA HB1960

Felony offenses; elimination of mandatory minimum sentences.

VA SB1084

Prescription of Schedule VI controlled substances; asynchronous interactions.

VA HB2465

Prescription drugs; return of drugs past their expiration dates.

VA HB1750

Cannabis control; establishes framework for creation of retail marijuana market.

VA HB921

Controlled substances; prescriber may establish practitioner-patient relationship.

Similar Bills

CA SB561

Hazardous waste: Emergency Distress Flare Safe Disposal Act.

CA AB2754

Alcoholic beverage control.

NH HB1358

Relative to tenant and contract manufacturers of beer, wine, and liquor; allowing pharmacists to administer influenza, COVID-19, and other FDA licensed vaccines without explicit approval from the general court; and, restricting the purchase of real property on or around military installations.

CA SB1445

Electric mobility manufacturers.

CA SB788

Beer manufacturers: cider and perry.

CA AB326

Electric mobility manufacturers.

CA AB1211

Electric mobility manufacturers.

CA SB1420

Licensed beer manufacturers: nonlicensee products: storage.